Novalis
The rounds this investor is named on, who it invests beside, and where it shows up.
The rounds this investor is named on, who it invests beside, and where it shows up.
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Airna AIRNA develops RNA editing therapeutics aimed at delivering functional cures for patients with rare diseases and common conditions. | Initial financing Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2023-09-19 | [ PART ] |